Genomic Health (GHDX) Reports Q3 Loss Per Share of 36c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Raymond James Upgrades Genomic Health Inc. (GHDX) to Outperform
November 4, 2015 7:11 AM ESTRaymond James upgraded Genomic Health Inc. (NASDAQ: GHDX) from Market Perform to Outperform with a price target of $29.00.
For an analyst ratings summary and ratings history on Genomic Health Inc. click here. For more ratings news on Genomic Health Inc. click here.
Shares of Genomic Health Inc. closed at $22.33 yesterday.
... More